Treatment Patterns and Overall Survival Outcomes Among Patients Aged 80 yr or Older with High-risk Prostate Cancer

Siegel, 2020, Cancer statistics, 2020, CA Cancer J Clin, 70, 7, 10.3322/caac.21590 Dy, 2017, Global burden of urologic cancers, 1990–2013, Eur Urol, 71, 437, 10.1016/j.eururo.2016.10.008 Etzioni, 2002, Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends, J Natl Cancer Inst, 94, 981, 10.1093/jnci/94.13.981 Lee, 2017, Recent changes in prostate cancer screening practices and epidemiology, J Urol, 198, 1230, 10.1016/j.juro.2017.05.074 National Comprehensive Cancer Network. Prostate cancer early detection (version 2.2020). 2020. https://www.nccn.org/professionals/physician_gls/pdf/prostate_detection.pdf. US Preventive Services Task Force, 2018, Screening for prostate cancer: US Preventive Services Task Force recommendation statement, JAMA, 319, 1901, 10.1001/jama.2018.3710 American Urological Association. Early detection of prostate cancer. 2018. https://www.auanet.org/guidelines/prostate-cancer-early-detection-guideline. Carter, 2013, Early detection of prostate cancer: AUA guideline, J Urol, 190, 419, 10.1016/j.juro.2013.04.119 National Comprehensive Cancer Network. Prostate cancer (version 2.2020). 2020. https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf. Stangelberger, 2008, Prostate cancer in elderly men, Rev Urol, 10, 111 Samet, 1986, Choice of cancer therapy varies with age of patient, JAMA, 255, 3385, 10.1001/jama.1986.03370240055036 Fischer-Valuck, 2018, Treatment patterns and overall survival outcomes of octogenarians with muscle invasive cancer of the bladder: an analysis of the National Cancer Database, J Urol, 199, 416, 10.1016/j.juro.2017.08.086 Newschaffer, 2000, Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort, J Natl Cancer Inst, 92, 613, 10.1093/jnci/92.8.613 Wong, 2006, Survival associated with treatment vs observation of localized prostate cancer in elderly men, JAMA, 296, 2683, 10.1001/jama.296.22.2683 Cooperberg, 2008, High-risk prostate cancer in the United States, 1990–2007, World J Urol, 26, 211, 10.1007/s00345-008-0250-7 Crawford, 2009, Understanding the epidemiology, natural history, and key pathways involved in prostate cancer, Urology, 73, S4, 10.1016/j.urology.2009.03.001 Konety, 2008, Patterns of primary and secondary therapy for prostate cancer in elderly men: analysis of data from CaPSURE, J Urol, 179, 1797, 10.1016/j.juro.2008.01.044 Bill-Axelson, 2005, Radical prostatectomy versus watchful waiting in early prostate cancer, N Engl J Med, 352, 1977, 10.1056/NEJMoa043739 Hamdy, 2016, 10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer, N Engl J Med, 375, 1415, 10.1056/NEJMoa1606220 Droz, 2017, Management of prostate cancer in elderly patients: recommendations of a task force of the International Society of Geriatric Oncology, Eur Urol, 72, 521, 10.1016/j.eururo.2016.12.025 Rider, 2013, Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based study, Eur Urol, 63, 88, 10.1016/j.eururo.2012.08.001 Leow, 2016, Robot-assisted versus open radical prostatectomy: a contemporary analysis of an all-payer discharge database, Eur Urol, 70, 837, 10.1016/j.eururo.2016.01.044 Sheets, 2012, Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer, JAMA, 307, 1611, 10.1001/jama.2012.460 Pan, 2018, Comparative toxicities and cost of intensity-modulated radiotherapy, proton radiation, and stereotactic body radiotherapy among younger men with prostate cancer, J Clin Oncol, 36, 1823, 10.1200/JCO.2017.75.5371 Social Security Administration. Actuarial life table 2020. https://www.ssa.gov/OACT/STATS/table4c6.html. O'Farrell, 2015, Risk and timing of cardiovascular disease after androgen-deprivation therapy in men with prostate cancer, J Clin Oncol, 33, 1243, 10.1200/JCO.2014.59.1792 Saigal, 2007, Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer, Cancer, 110, 1493, 10.1002/cncr.22933 Keating, 2010, Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer, J Natl Cancer Inst, 102, 39, 10.1093/jnci/djp404 Motlagh, 2021, The risk of new onset dementia and/or Alzheimer's disease among prostate cancer patients treated with androgen deprivation therapy: a systematic review and meta-analysis, J Urol, 205, 60, 10.1097/JU.0000000000001341 Wong, 2009, The role of primary androgen deprivation therapy in localized prostate cancer, Eur Urol, 56, 609, 10.1016/j.eururo.2009.03.066